Magdalena Klink Selected Research

1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazene

10/2016	Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.
1/2015	Antitumoral Activity Of Nitric Oxide-Releasing Compounds.
11/2014	Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro.
11/2013	Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Klink Research Topics

Disease

16	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2012
14	Neoplasms (Cancer) 01/2022 - 01/2012
6	Infections 01/2019 - 01/2003
3	Ovarian Epithelial Carcinoma 09/2020 - 01/2017
2	Necrosis 12/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2018 - 02/2016
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2014
2	Coronary Disease (Coronary Heart Disease) 12/2003 - 04/2003
2	Inflammation (Inflammations) 01/2003 - 08/2002
1	Cysts 01/2022
1	Carcinogenesis 01/2022
1	Ovarian Cysts (Ovarian Cyst) 01/2022
1	Ascites 12/2021
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Tuberculosis (Tuberculoses) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 04/2018
1	Anaphylaxis (Anaphylactic Shock) 10/2003

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2015
5	CytokinesIBA 12/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 11/2014
4	Biological ProductsIBA 01/2017 - 11/2012
4	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 10/2016 - 11/2013
3	ChemokinesIBA 01/2022 - 01/2020
3	Nitric Oxide DonorsIBA 10/2016 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2021
2	AntigensIBA 11/2021 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2021 - 09/2020
2	Interleukin-2 (IL2)IBA 12/2020 - 01/2012
2	MicroRNAs (MicroRNA)IBA 09/2020 - 01/2020
2	EnzymesIBA 01/2020 - 02/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 11/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 11/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017 - 11/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 02/2013
2	spermine nitric oxide complexIBA 10/2016 - 01/2015
2	SpermineIBA 11/2014 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013 - 01/2013
2	Molsidomine (SIN 10)IBA 12/2003 - 04/2003
2	Opioid Peptides (Opioid Peptide)IBA 01/2003 - 08/2002
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	CalreticulinIBA 11/2021
1	Interleukin-12 (IL 12)IBA 12/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020
1	InterferonsIBA 12/2020
1	InterleukinsIBA 12/2020
1	ParaffinIBA 09/2020
1	Formaldehyde (Formol)FDA Link 09/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	ZM 241385 (ZM241385)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	1- butyl- 8- (3- noradamantyl)- 3- (3- hydroxypropyl)xanthineIBA 01/2019
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 04/2018
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	L-SelectinIBA 02/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2015
1	Cytostatic AgentsIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	Metalloproteases (Metalloproteinases)IBA 11/2014
1	Matrix Metalloproteinases (MMPs)IBA 11/2014
1	CarbonIBA 02/2013
1	CholesterolIBA 02/2013
1	ImmunosorbentsIBA 02/2013
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 12/2003
1	LectinsIBA 10/2003
1	LipopolysaccharidesIBA 10/2003
1	Lipid AIBA 10/2003
1	Complement System Proteins (Complement)IBA 10/2003
1	Recombinases (Recombinase)IBA 10/2003
1	Urea (Carbamide)FDA LinkGeneric 01/2003
1	AntibodiesIBA 01/2003

Therapy/Procedure

8	Therapeutics 12/2021 - 04/2003
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2018
1	Radiotherapy 11/2021
1	Photochemotherapy (Photodynamic Therapy) 11/2021